This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
From 1 January 2022, the listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Published 16 December 2021 Last updated 12 July 2022 +show all updates
Updated to remove Glucagon 0.5mg solution for injection in pre-filled pen from the list.
Added Silver Sulfadiazine Cream 1%, Glucagon 0.5mg solution for injection in pre-filled pen, Glucagon 1mg solution for injection in pre-filled pen.Removed Estradiol 0.06% gel (750microgram per actuation).
Replaced spreadsheet with updated version with the following listing: 'Fondaparinux sodium 7.5mg/0.6ml solution for injection, pre-filled syringe'.
Added fondaparinux 5mg, 7mg and 10mg to the list of medicines that can be moved through NIMAR.
Added bexarotene 75mg capsules to and removed eltrombopag 75mg capsules and thiopental from the list of medicines that can be moved through NIMAR.
Replaced spreadsheet with updated version listing Buccolam as the brand name for Midazolam.
Added Acetylcysteine, Canagliflozin, Eltrombopag, Estradiol, Insulin isophane, Midazolam, Progesterone and Topotecan to the list of medicines that can be moved through NIMAR.
Added Etanercept 50mg/1ml, Somatropin (rbe) (5mg/1.5ml, 10mg/1.5ml, 15mg/1.5ml) and Thiopental 500mg powder to the list of medicines that can be moved through NIMAR.
Added 'Cobimetinib 20mg tablets' to the list of medicines that can be moved through NIMAR.
Added 2 new lines to the list: sodium chloride 0.18% + glucose 4% infusion bags and sucralfate 1g/5ml liquid.
